References
- Shields JA, Demirci H, Marr BP, et al. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005;50:103–122.
- Shields JA, Demirci H, Marr BP, et al. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology. 2004;111:2151–2157.
- Chang K, Wileman JM, Gabbard RD, et al. Isolated primary sebaceous gland carcinoma of the bulbar conjunctiva. Am J Ophthalmol Case Rep. 2022;27:101675.
- Chao AN, Shields CL, Krema H, et al. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophthalmology. 2001;108:1877–1883.
- Vittoria Cicinelli M, Kaliki S. Ocular sebaceous gland carcinoma: an update of the literature. Int Ophthalmol. 2018;39(5):1187–1197.
- Zihan N, Xiaolin X, Bin L, et al. Prognostic factors of 354 cases for eyelid sebaceous gland carcinoma. Eye. 2022;31:104–108.
- Xu XL, Li B, Sun XL, et al. Eyelid neoplasms in the Beijing Tongren eye centre between 1997 and 2006. Ophthalmic Surg Lasers Imaging. 2008;39:367–372.
- Cook BE, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County. Minnesota Ophthalmol. 1999;106:746–750.
- Buitrago W, Joseph AK. Sebaceous carcinoma: the great Masquerader. Dermatol Ther. 2008;21:459–466.
- Shuang W, Wei C, Tao Z, et al. The CT and MRI Findings and Differential Diagnosis of Sebaceous Carcinoma of Eyelid and Basal Cell Carcinoma. CTTA. 2022;31(5):662–668.
- Aiping K, Lixing W, Juan L. Radiographic findings of meibomian adenocarcinoma. HeiLongjiang Med J. 2014;38(9):1027–1028.
- Sahni V, Cassarino DS. Sebaceous Carcinoma of the Penis: a Rare, Dangerous Clinical Entity and the Importance of Immunohistochemistry in Diagnosis. Case Rep Dermatol Med. 2023;2023:6944296.
- Asadi-Amoli F, Khoshnevis F, Haeri H, et al. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell carcinoma and basal cell carcinoma. Am J Clin Pathol. 2010;134:22–26.
- Mulay K, White VA, Shah SJ, et al. Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor). Can J Ophthalmol. 2014;49(4):326–332.
- Mulay K, Shah SJ, Aggarwal E, et al. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance? Acta Ophthalmol. 2014;92:e681–e687.
- i AS, Takeichi H, Arase S, et al. Sebaceous carcinoma: an immunohistochemical reappraisal. Am J Dermatopath. 2011;33(6):579–587.
- Ansai S, Arase S, Kawana S, et al. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies. J Dermatol. 2011;38:951–958.
- Qun L, Xiaoyue F, Huang Y. Sebaceous carcinoma of the right palate: case report and literature review. Gland Surg. 2021;10(5):1819–1825.
- Soares CD, Morais TML, Carlos R, et al. Sebaceous adenocarcinomas of the major salivary glands: a clinicopathological analysis of 10 cases. Histopathology. 2018;73(4):585–592.
- Plaza JA, Mackinnon A, Carrillo L, et al. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study. Am J Dermatopath. 2015;37(11):809–821.
- Wei J, Luo G, Shi Y, et al. Sebaceous Carcinoma of the Submandibular Gland a Case Report and Review of the Literature. Cancer Manag Res. 2023;15:123–130.
- AlHammad F, Edward D, Alkatan HM, et al. Eyelid sebaceous gland carcinoma: an assessment of the T classification of the American Joint Committee of Cancer TNM staging system 8th versus. Eur J Ophthalmol. 2021;31(4):2055–2063.
- Takahashi Y, Takahashi E, Nakakura S, et al. Risk factors for local recurrence or metastasis of eyelid sebaceous gland carcinoma after wide excision with paraffin section control. Am J Ophthalmol. 2016;171:67–74.